Encontrados 24 documentos, a visualizar página 1 de 3
Dor na doença de Parkinson
Vila-Chã, Nuno; Gonçalves, Alexandra; Moreira, Inês; Mendes, Alexandre; Azevedo, LF; Cavaco, Sara; Castro-Lopes, JM
Recomendações para Análise Mutacional em Tumores do Estroma Gastrointestinal (G...
Lopes, JM; Soares, M; Gouveia, AM; Barroso, S; Cravo, M; Mansinho, H; Penedo, J; Sá, A; Santos, LL; Teixeira, JAOs autores apresentam as recomendações para a análise mutacional de GISTs, aprovadas por unanimidade por um grupo multidisciplinar em 20 de Julho de 2012. O estado mutacional de genes como o KIT e o PDGFRA permite identificar alvos terapêuticos para inibidores da tirosinacínase (ITKs) e, por isso, a boa prática clínica nas decisões bioterapêuticas de doentes com GISTs deve incluir a análise do estado mutacional...
mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma
Faustino, A; Couto, JP; Pópulo, H; Rocha, AS; Pardal, F; Cameselle-Teijeiro, JM; Lopes, JM; Sobrinho-Simões, M; Soares, PCONTEXT: There are several genetic and molecular evidences suggesting dysregulation of the mammalian target of rapamycin (mTOR) pathway in thyroid neoplasia. Activation of the phosphatidylinositol-3-kinase/AKT pathway by RET/PTC and mutant RAS has already been demonstrated, but no data have been reported for the BRAF(V600E) mutation. OBJECTIVE: The aim of this study was to evaluate the activation pattern of the...
mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma
Faustino, A; Couto, JP; Pópulo, H; Rocha, AS; Pardal, F; Cameselle-Teijeiro, JM; Lopes, JM; Sobrinho-Simões, M; Soares, PCONTEXT: There are several genetic and molecular evidences suggesting dysregulation of the mammalian target of rapamycin (mTOR) pathway in thyroid neoplasia. Activation of the phosphatidylinositol-3-kinase/AKT pathway by RET/PTC and mutant RAS has already been demonstrated, but no data have been reported for the BRAF(V600E) mutation. OBJECTIVE: The aim of this study was to evaluate the activation pattern of the...
Avaliação e Tratamento do Doente com Acne - Parte I: Epidemiologia, Etiopatogen...
Figueiredo, A; Massa, A; Picoto, A; Pinto Soares, A; Basto, AS; Campos Lopes, JM; Resende, C; Rebelo, C; Brandão, FM; Marques Pinto, G; Oliveira, HSO Portuguese Acne Advisory Board (PAAB), grupo de dermatologistas portugueses que, à semelhança de grupos congéneres internacionais, tem dedicado particular atenção à definição de linhas de orientação para o tratamento da acne, pretende que o presente documento constitua uma ferramenta útil na abordagem dos doentes com esta patologia. Elaborou-se um dossier, para educação médica contínua, subdividido em 2 parte...
Avaliação e Tratamento do Doente com Acne - Parte II: Tratamento Tópico, Sistém...
Figueiredo, A; Massa, A; Picoto, A; Pinto Soares, A; Basto, AS; Campos Lopes, JM; Resende, C; Rebelo, C; Brandão, FM; Marques Pinto, G; Oliveira, HSO Portuguese Acne Advisory Board (PAAB), grupo de dermatologistas portugueses que, à semelhança de grupos congéneres internacionais, tem dedicado particular atenção à definição de linhas de orientação para o tratamento da acne, pretende que o presente documento constitua uma ferramenta útil na abordagem dos doentes com esta patologia. Elaborou-se um dossier, para educação médica contínua, subdividido em 2 parte...
Impact of EGFR genetic variants on glioma risk and patient outcome
Costa, BM; Viana-Pereira, M; Fernandes, R; Costa, S; Linhares, P; Vaz, R; Pinheiro, C; Lima, J; Soares, P; Silva, A; Pardal, F; Amorim, J; Nabiço, RBACKGROUND: The epidermal growth factor receptor (EGFR) regulates important cellular processes and is frequently implicated in human tumors. Three EGFR polymorphisms have been described as having a transcriptional regulatory function: two single-nucleotide polymorphisms in the essential promoter region, -216G/T and -191C/A, and a polymorphic (CA)(n) microsatellite sequence in intron 1. We aimed to elucidate the...
Impact of EGFR genetic variants on glioma risk and patient outcome
Costa, BM; Viana-Pereira, M; Fernandes, R; Costa, S; Linhares, P; Vaz, R; Pinheiro, C; Lima, J; Soares, P; Silva, A; Pardal, F; Amorim, J; Nabiço, RBACKGROUND: The epidermal growth factor receptor (EGFR) regulates important cellular processes and is frequently implicated in human tumors. Three EGFR polymorphisms have been described as having a transcriptional regulatory function: two single-nucleotide polymorphisms in the essential promoter region, -216G/T and -191C/A, and a polymorphic (CA)(n) microsatellite sequence in intron 1. We aimed to elucidate the...
Prognostic value of MGMT promoter methylation in glioblastoma patients treated ...
Costa, BM; Caeiro, C; Guimarães, I; Martinho, O; Jaraquemada, T; Augusto, I; Castro, l; Osório, L; Linhares, P; Honavar, M; Resende, M; Nabiço, RGlioblastoma (GBM) is the most common and aggressive primary brain tumor. The identification of novel molecular prognostic markers of GBM has recently been an area of great interest in neuro-oncology. The methylation status of the MGMT gene promoter is currently a promising molecular prognostic marker, but some controversial data have precluded its clinical use. We analyzed MGMT methylation by methylation-speci...
Prognostic value of MGMT promoter methylation in glioblastoma patients treated ...
Costa, BM; Caeiro, C; Guimarães, I; Martinho, O; Jaraquemada, T; Augusto, I; Castro, l; Osório, L; Linhares, P; Honavar, M; Resende, M; Nabiço, RGlioblastoma (GBM) is the most common and aggressive primary brain tumor. The identification of novel molecular prognostic markers of GBM has recently been an area of great interest in neuro-oncology. The methylation status of the MGMT gene promoter is currently a promising molecular prognostic marker, but some controversial data have precluded its clinical use. We analyzed MGMT methylation by methylation-speci...
| Financiadores do RCAAP | |||||||
|
|
|
|
|
|
||